As of 2025-09-18, the Intrinsic Value of Immunic Inc (IMUX) is -5.16 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.83 USD, the upside of Immunic Inc is -722.09%.
Based on its market price of 0.83 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 722.09%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.16 - -5.16 | -5.16 | -722.09% |
| P/E | (27.38) - (3.28) | (18.48) | -2327.1% |
| DDM - Stable | (6.31) - (29.28) | (17.80) | -2244.9% |
| DDM - Multi | (0.75) - (2.82) | (1.19) | -243.7% |
| Market Cap (mil) | 81.85 |
| Beta | 1.07 |
| Outstanding shares (mil) | 98.65 |
| Enterprise Value (mil) | 26.54 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.31% |
| Cost of Debt | 5.00% |
| WACC | 7.49% |